Recent Advances and Disputes About Curcumin in Retinal Diseases

References

• López-Malo D, Villarón-Casares CA, Alarcón-Jiménez J, et al. Curcumin as a Therapeutic Option in Retinal Diseases. Antioxidants. 2020;9(1):48. doi:10.3390/antiox9010048
   Web of Science ®Google Scholar
• Rodríguez Castaño P, Parween S, Pandey AV. Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway. Int J Mol Sci. 2019;20(18):4606. doi:10.3390/ijms20184606.
   PubMed Web of Science ®Google Scholar
• Mirzaee F, Hosseinzadeh L, Ashrafi-Kooshk MR, et al. Diverse Effects of Different “Protein-Based” Vehicles on the Stability and Bioavailability of Curcumin: spectroscopic Evaluation of the Antioxidant Activity and Cytotoxicity In Vitro. Protein Pept Lett. 2019;26(2):132–147. doi:10.2174/0929866525666181114152242.
   Web of Science ®Google Scholar
• Perrone D, Ardito F, Giannatempo G, et al. Biological and therapeutic activities, and anticancer properties of curcumin. Exp Ther Med. 2015;10(5):1615–1623. doi:10.3892/etm.2015.2749
   PubMed Web of Science ®Google Scholar
• Pescosolido N, Giannotti R, Plateroti AM, Pascarella A, Nebbioso M. Curcumin: therapeutical potential in ophthalmology. Planta Med. 2014;80(4):249–254. doi:10.1055/s-0033-1351074
   PubMed Web of Science ®Google Scholar
• Deogade S, Ghate S. Curcumın: therapeutıc applıcatıons in systemıc and oral health. Int J Biol Pharm Res. 2015;6(4):281–290.
   Google Scholar
• Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors. 2013;39(1):2–13. doi:10.1002/biof.1079
   PubMed Web of Science ®Google Scholar
• Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med. 1991;57(1):1–7. doi:10.1055/s-2006-960004
   PubMed Web of Science ®Google Scholar
• Takahashi M, Ishiko T, Kamohara H, et al. Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) blocks the chemotaxis of neutrophils by inhibiting signal transduction through IL-8 receptors. Mediators Inflamm. 2007;2007:10767. doi:10.1155/2007/10767
   Web of Science ®Google Scholar
• Lestari ML, Indrayanto G. Curcumin. Profiles Drug Subst Excip Relat Methodol. 2014;39:113–204. doi:10.1016/B978-0-12-800173-8.00003-9
   PubMedGoogle Scholar
• Mahady GB, Pendland SL, Yun G, Lu ZZ. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res. 2002;22(6C):4179–4181.
   PubMed Web of Science ®Google Scholar
• Reddy DNK, Huang FY, Wang SP, Kumar R. Synergistic antioxidant and antibacterial activity of curcumin-C3 encapsulated chitosan nanoparticles. Curr Pharm Des. 2020;26(39):5021–5029. doi:10.2174/1381612826666200609164830
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–818. doi:10.1021/mp700113r
   PubMed Web of Science ®Google Scholar
• Payton F, Sandusky P, Alworth WL. NMR study of the solution structure of curcumin. J Nat Prod. 2007;70(2):143–146. doi:10.1021/np060263s
   PubMed Web of Science ®Google Scholar
• Radomska-Leśniewska DM, Osiecka-Iwan A, Hyc A, Góźdź A, Dąbrowska AM, Skopiński P. Therapeutic potential of curcumin in eye diseases. Cent Eur J Immunol. 2019;44(2):181–189. doi:10.5114/ceji.2019.87070
   PubMed Web of Science ®Google Scholar
• Srinivas C, Prabhakaran KV. Haridra (curcuma longa) and its effect on abhisayanda (conjunctivitis). Anc Sci Life. 1989;8(3–4):279–282.
   Google Scholar
• Awasthi S, Srivatava SK, Piper JT, Singhal SS, Chaubey M, Awasthi YC. Curcumin protects against 4-hydroxy-2-trans-nonenal-induced cataract formation in rat lenses. Am J Clin Nutr. 1996;64(5):761–766. doi:10.1093/ajcn/64.5.761.
   PubMed Web of Science ®Google Scholar
• Lal B, Kapoor AK, Asthana OP, et al. Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res. 1999;13(4):318–322. doi:10.1002/(SICI)1099-1573(199906)13:4<318:AID-PTR445>3.0.CO;2-7
   PubMed Web of Science ®Google Scholar
• Wang LL, Sun Y, Huang K, Zheng L. Curcumin, a potential therapeutic candidate for retinal diseases. Mol Nutr Food Res. 2013;57(9):1557–1568. doi:10.1002/mnfr.201200718
   PubMed Web of Science ®Google Scholar
• Noorafshan A, Ashkani-Esfahani S. A review of therapeutic effects of curcumin. Curr Pharm Des. 2013;19(11):2032–2046.
   PubMed Web of Science ®Google Scholar
• Masuda T, Hidaka K, Shinohara A, Maekawa T, Takeda Y, Yamaguchi H. Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products from curcumin. J Agric Food Chem. 1999;47(1):71–77. doi:10.1021/jf9805348
   PubMed Web of Science ®Google Scholar
• Wang YJ, Pan MH, Cheng AL, et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. 1997;15(12):1867–1876. doi:10.1016/s0731-7085(96)02024-9
   PubMed Web of Science ®Google Scholar
• Guo LY, Cai XF, Lee JJ, et al. Comparison of suppressive effects of demethoxycurcumin and bisdemethoxycurcumin on expressions of inflammatory mediators in vitro and in vivo. Arch Pharm Res. 2008;31(4):490–496. doi:10.1007/s12272-001-1183-8
   Web of Science ®Google Scholar
• Kocaadam B, Şanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017;57(13):2889–2895. doi:10.1080/10408398.2015.1077195
   PubMed Web of Science ®Google Scholar
• Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules. 2014;19(12):20091–20112. doi:10.3390/molecules191220091
   PubMed Web of Science ®Google Scholar
• Peddada KV, Brown A, Verma V, Nebbioso M. Therapeutic potential of curcumin in major retinal pathologies. Int Ophthalmol. 2019;39(3):725–734. doi:10.1007/s10792-018-0845-y
   PubMed Web of Science ®Google Scholar
• Gupta SK, Kumar B, Nag TC, et al. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther. 2011;27(2):123–130. doi:10.1089/jop.2010.0123
   PubMed Web of Science ®Google Scholar
• Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem. 1995;270(42):24995–25000. doi:10.1074/jbc.270.42.24995
   PubMed Web of Science ®Google Scholar
• Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci. 2005;1056:206–217. doi:10.1196/annals.1352.010
   PubMed Web of Science ®Google Scholar
• Devasagayam TP, Sainis KB. Immune system and antioxidants, especially those derived from Indian medicinal plants. Indian J Exp Biol. 2002;40(6):639–655.
   PubMedGoogle Scholar
• Amor S, Puentes F, Baker D, van der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129(2):147–309. doi:10.1111/j.1365-2567.2009.03225.x
   Web of Science ®Google Scholar
• Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40–59. doi:10.1016/j.biocel.2008.06.010
   PubMed Web of Science ®Google Scholar
• Priyadarsini KI. Free radical reactions of curcumin in membrane models. Free Radic Biol Med. 1997;23(6):838–843. doi:10.1016/s0891-5849(97)00026-9
   Web of Science ®Google Scholar
• Gorman AA, Hamblett I, Srinivasan VS, Wood PD. Curcumin-derived transients: a pulsed laser and pulse radiolysis study. Photochem Photobiol. 1994;59(4):389–398. doi:10.1111/j.1751-1097.1994.tb05053.x
   Web of Science ®Google Scholar
• Sugiyama Y, Kawakishi S, Osawa T. Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol. 1996;52(4):519–525. doi:10.1016/0006-2952(96)00302-4
   PubMed Web of Science ®Google Scholar
• Jovanovic SV, Boone CW, Steenken S, Trinoga M, Kaskey RB. How curcumin works preferentially with water soluble antioxidants. J Am Chem Soc. 2001;123(13):3064–3068. doi:10.1021/ja003823x
   PubMed Web of Science ®Google Scholar
• Litwinienko G, Ingold KU. Abnormal solvent effects on hydrogen atom abstraction. 2. Resolution of the curcumin antioxidant controversy. The role of sequential proton loss electron transfer. J Org Chem. 2004;69(18):5888–5896. doi:10.1021/jo049254j
   PubMed Web of Science ®Google Scholar
• Ushio-Fukai M, Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem. 2004;264(1–2):85–97. doi:10.1023/B:MCBI.0000044378.09409.b5
   PubMed Web of Science ®Google Scholar
• Chen WH, Chen Y, Cui GH. Effects of TNF-alpha and curcumin on the expression of VEGF in Raji and U937 cells and on angiogenesis in ECV304 cells. Chin Med J. 2005;118(24):2052–2057.
   Web of Science ®Google Scholar
• Millanta F, Citi S, Della Santa D, Porciani M, Poli A. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers. Breast Cancer Res Treat. 2006;98(1):115–120. doi:10.1007/s10549-005-9138-z.
   Web of Science ®Google Scholar
• Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol. 2008;14(13):2003–2009. doi:10.3748/wjg.14.2003
   PubMed Web of Science ®Google Scholar
• Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer. 2005;104(6):1322–1331. doi:10.1002/cncr.21300
   PubMed Web of Science ®Google Scholar
• Ravindran J, Prasad S, Aggarwal BB. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 2009;11(3):495–510. doi:10.1208/s12248-009-9128-x.
   PubMed Web of Science ®Google Scholar
• Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18):2081–2087. doi:10.1016/j.lfs.2005.12.007
   PubMed Web of Science ®Google Scholar
• Devassy JG, Nwachukwu ID, Jones PJ. Curcumin and cancer: barriers to obtaining a health claim. Nutr Rev. 2015;73(3):155–165. doi:10.1093/nutrit/nuu064
   PubMed Web of Science ®Google Scholar
• Sidhu GS, Singh AK, Thaloor D, et al. Enhancement of wound healing by curcumin in animals. Wound Repair Regen. 1998;6(2):167–177. doi:10.1046/j.1524-475x.1998.60211.x
   PubMedGoogle Scholar
• Munia I, Gafray L, Bringer MA, et al. Cytoprotective effects of natural highly bio-available vegetable derivatives on human-derived retinal cells. Nutrients. 2020;12(3):879. doi:10.3390/nu12030879
   Web of Science ®Google Scholar
• Lal B, Kapoor AK, Asthana OP, et al. Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res. 1999;13(4):318–322. doi:10.1002/(SICI)1099-1573(199906)13:
   PubMed Web of Science ®Google Scholar
• Allegri P, Mastromarino A, Neri P. Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-Term Follow-Up Clin Ophthalmol. 2010;4:1201–1206. doi:10.2147/OPTH.S13271.
   Google Scholar
• Miserocchi E, Giuffrè C, Cicinelli MV, et al. Oral phospholipidic curcumin in juvenile idiopathic arthritis-associated uveitis. Eur J Ophthalmol. 2019:1120672119892804. doi:10.1177/1120672119892804
   Web of Science ®Google Scholar
• Mandal MN, Patlolla JM, Zheng L, et al. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radic Biol Med. 2009;46(5):672–679. doi:10.1016/j.freeradbiomed.2008.12.006
   Web of Science ®Google Scholar
• Muangnoi C, Sharif U. Protective effects of curcumin ester prodrug, curcumin diethyl disuccinate against H2O2-induced oxidative stress in human retinal pigment epithelial cells: potential therapeutic avenues for age-related macular degeneration. Int J Mol Sci. 2019;20(13):3367. doi:10.3390/ijms20133367
   Web of Science ®Google Scholar
• Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care. 2003;26(9):2653–2664. doi:10.2337/diacare.26.9.2653
   PubMed Web of Science ®Google Scholar
• Cheung N, Wong IY, Wong TY. Ocular anti-VEGF therapy for diabetic retinopathy: overview of clinical efficacy and evolving applications. Diabetes Care. 2014;37(4):900–905. doi:10.2337/dc13-1990
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kanwar M. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab. 2007;4:8. doi:10.1186/1743-7075-4-8
   Google Scholar
• Chiu J, Xu BY, Chen S, Feng B, Chakrabarti S. Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications. Can J Physiol Pharmacol. 2008;86(6):365–372. doi:10.1139/Y08-033
   PubMed Web of Science ®Google Scholar
• Premanand C, Rema M, Sameer MZ, Sujatha M, Balasubramanyam M. Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Invest Ophthalmol Vis Sci. 2006;47(5):2179–2184. doi:10.1167/iovs.05-0580
   Web of Science ®Google Scholar
• Wang C, Nie H, Li K, et al. Curcumin inhibits HMGB1 releasing and attenuates concanavalin A-induced hepatitis in mice. Eur J Pharmacol. 2012;697(1–3):152–157. doi:10.1016/j.ejphar.2012.09.050
   Web of Science ®Google Scholar
• Kumar PA, Haseeb A, Suryanarayana P, Ehtesham NZ, Reddy GB. Elevated expression of alphaA- and alphaB-crystallins in streptozotocin-induced diabetic rat. Arch Biochem Biophys. 2005;444(2):77–83. doi:10.1016/j.abb.2005.09.021
   Web of Science ®Google Scholar
• Mrudula T, Suryanarayana P, Srinivas PNBS, Reddy GB. Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. Biochem Biophys Res Commun. 2007;361(2):528–532. doi:10.1016/j.bbrc.2007.07.059
   PubMed Web of Science ®Google Scholar
• Khimmaktong W, Petpiboolthai H, Sriya P, Anupunpisit V. Effects of curcumin on restoration and improvement of microvasculature characteristic in diabetic rat’s choroid of eye. J Med Assoc Thai. 2014;97(Suppl 2):S39–46.
   Google Scholar
• Ran Z, Zhang Y, Wen X, Ma J. Curcumin inhibits high glucose induced inflammatory injury in human retinal pigment epithelial cells through the ROS PI3K/AKT/mTOR signaling pathway. Mol Med Rep. 2019;19(2):1024–1031. doi:10.3892/mmr.2018.9749
   Web of Science ®Google Scholar
• Mazzolani F, Togni S. Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study. Clin Ophthalmol. 2013;7:939–945. doi:10.2147/OPTH.S45820
   PubMedGoogle Scholar
• Ferrara M, Allegrini D, Sorrentino T, et al. Curcumin-based treatment for macular edema from uncommon etiologies: efficacy and safety assessment. J Med Food. 2020;23(8):834–840. doi:10.1089/jmf.2019.0241
   PubMed Web of Science ®Google Scholar
• Wang L, Li C, Guo H, Kern TS, Huang K, Zheng L. Curcumin inhibits neuronal and vascular degeneration in retina after ischemia and reperfusion injury. PLoS One. 2011;6(8):e23194. doi:10.1371/journal.pone.0023194
   PubMed Web of Science ®Google Scholar
• Wang S, Ye Q, Tu J, Zhang M, Ji B. Curcumin protects against hypertension aggravated retinal ischemia/reperfusion in a rat stroke model. Clin Exp Hypertens. 2017;39(8):711–717. doi:10.1080/10641963.2017.1313854
   PubMed Web of Science ®Google Scholar
• Ren YX, Ma JX, Zhao F, An JB, Geng YX, Liu LY. Effects of curcumin on epidermal growth factor in proliferative vitreoretinopathy. Cell Physiol Biochem. 2018;47(5):2136–2146. doi:10.1159/000491525
   Google Scholar
• Khan MI, Kersten FF, Azam M, et al. CLRN1 mutations cause nonsyndromic retinitis pigmentosa. Ophthalmology. 2011;118(7):1444–1448. doi:10.1016/j.ophtha.2010.10.047
   PubMed Web of Science ®Google Scholar
• Limoli PG, Vingolo EM, Limoli C, Nebbioso M. Antioxidant and biological properties of mesenchymal cells used for therapy in retinitis pigmentosa. Antioxidants. 2020;9(10):E983. doi:10.3390/antiox9100983
   Web of Science ®Google Scholar
• Pagon RA. Retinitis pigmentosa. Surv Ophthalmol. 1988;33(3):137–177. doi:10.1016/0039-6257(88)90085-9
   PubMed Web of Science ®Google Scholar
• Daiger SP, Sullivan LS, Bowne SJ. Genes and mutations causing retinitis pigmentosa. Clin Genet. 2013;84(2):132–141. doi:10.1111/cge.12203
   PubMed Web of Science ®Google Scholar
• Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795–1809. doi:10.1016/S0140-6736(06)69740-7
   PubMed Web of Science ®Google Scholar
• Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1(1):40. doi:10.1186/1750-1172-1-40
   PubMed Web of Science ®Google Scholar
• Grover S, Fishman GA, Alexander KR, Anderson RJ, Derlacki DJ. Visual acuity impairment in patients with retinitis pigmentosa. Ophthalmology. 1996;103(10):1593–1600. doi:10.1016/s0161-6420(96)30458-2
   PubMed Web of Science ®Google Scholar
• McCulloch DL, Marmor MF, Brigell MG, et al. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015;130(1):1–12. doi:10.1007/s10633-014-9473-7
   PubMed Web of Science ®Google Scholar
• Liu G, Liu X, Li H, Du Q, Wang F. Optical coherence tomographic analysis of retina in retinitis pigmentosa patients. Ophthalmic Res. 2016;56(3):111–122. doi:10.1159/000445063
   PubMed Web of Science ®Google Scholar
• Smith LE. Bone marrow-derived stem cells preserve cone vision in retinitis pigmentosa. J Clin Invest. 2004;114(6):755–757. doi:10.1172/JCI22930
   Web of Science ®Google Scholar
• Dryja TP, Li T. Molecular genetics of retinitis pigmentosa. Hum Mol Genet. 1995;4:1739–1743. doi:10.1093/hmg/4.suppl_1.1739
   PubMed Web of Science ®Google Scholar
• Illing ME, Rajan RS, Bence NF, Kopito RR. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J Biol Chem. 2002;277:34150–34160. doi:10.1074/jbc.M204955200
   PubMed Web of Science ®Google Scholar
• Saliba RS, Munro PM, Luthert PJ, Cheetham ME. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. J Cell Sci. 2002;115(Pt 14):2907–2918. doi:10.1242/jcs.115.14.2907
   PubMed Web of Science ®Google Scholar
• Khajavi M, Shiga K, Wiszniewski W, et al. Oral curcumin mitigates the clinical and neuropathologic phenotype of the trembler-J mouse: a potential therapy for inherited neuropathy. Am J Hum Genet. 2007;81(3):438–453. doi:10.1086/519926
   PubMed Web of Science ®Google Scholar
• Vasireddy V, Chavali VR, Joseph VT, et al. Rescue of photoreceptor degeneration by curcumin in transgenic rats with P23H rhodopsin mutation. PLoS One. 2011;6(6):e21193. doi:10.1371/journal.pone.0021193
   PubMed Web of Science ®Google Scholar
• Emoto Y, Yoshizawa K, Uehara N, et al. Curcumin suppresses N-methyl-N-nitrosourea-induced photoreceptor apoptosis in Sprague-Dawley rats. Vivo. 2013;27(5):583–590.
   Web of Science ®Google Scholar
• Scott PA, Kaplan HJ, McCall MA. Prenatal exposure to curcumin protects rod photoreceptors in a transgenic Pro23His Swine model of retinitis pigmentosa. Transl Vis Sci Technol. 2015;4(5):5. doi:10.1167/tvst.4.5.5
   Web of Science ®Google Scholar
• Lin TC, Lin YY, Hsu CC, et al. Nanomedicine-based curcumin approach improved ros damage in best dystrophy-specific induced pluripotent stem cells. Cell Transplant. 2019;28(11):1345–1357. doi:10.1177/0963689719860130
   PubMed Web of Science ®Google Scholar
• Li Y, Sun W, Han N, Zou Y, Yin D. Curcumin inhibits proliferation, migration, invasion and promotes apoptosis of retinoblastoma cell lines through modulation of miR-99a and JAK/STAT pathway. BMC Cancer. 2018;18(1):1230. doi:10.1186/s12885-018-5130-y
   PubMed Web of Science ®Google Scholar
• Bar-Sela G, Epelbaum R, Schaffer M. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem. 2010;17(3):190–197. doi:10.2174/092986710790149738
   PubMed Web of Science ®Google Scholar
• Sharma RA, Steward WP, Gescher AJ. Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol. 2007;595:453–470. doi:10.1007/978-0-387-46401-5_20
   PubMed Web of Science ®Google Scholar
• Wahlström B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol. 1978;43(2):86–92. doi:10.1111/j.1600-0773.1978.tb02240.x
   PubMedGoogle Scholar
• Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;853(1–2):183–189. doi:10.1016/j.jchromb.2007.03.010
   PubMed Web of Science ®Google Scholar
• Noureddin SA, El-Shishtawy RM, Al-Footy KO. Curcumin analogues and their hybrid molecules as multifunctional drugs. Eur J Med Chem. 2019;182:111631. doi:10.1016/j.ejmech.2019.111631
   PubMed Web of Science ®Google Scholar
• Wang J, Xiong T, Zhou J, et al. Enzymatic formation of curcumin in vitro and in vivo. Nano Res. 2018;11:3453–3461. doi:10.1007/s12274-018-1994-z
   Web of Science ®Google Scholar
• Chen Y, Lu Y, Lee RJ, Xiang G. Nano encapsulated curcumin: and its potential for biomedical applications. Int J Nanomedicine. 2020;15:3099–3120. doi:10.2147/IJN.S210320
   PubMed Web of Science ®Google Scholar
• Wang L, Wang C, Tao Z, et al. Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer. J Exp Clin Cancer Res. 2019;38(1):460. doi:10.1186/s13046-019-1424-4
   PubMed Web of Science ®Google Scholar
• Ohori H, Yamakoshi H, Tomizawa M, et al. Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Mol Cancer Ther. 2006;5(10):2563–2571. doi:10.1158/1535-7163.MCT-06-0174
   Web of Science ®Google Scholar
• Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(4):353–356. doi:10.1055/s-2006-957450
   PubMed Web of Science ®Google Scholar
• Li M, Xin M, Guo C, Lin G, Wu X. New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment. Drug Dev Ind Pharm. 2017;43(11):1846–1857. doi:10.1080/03639045.2017.1349787
   PubMed Web of Science ®Google Scholar
• Barenholz Y. Doxil®--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117–134. doi:10.1016/j.jconrel.2012.03.020
   PubMed Web of Science ®Google Scholar
• Zhang W, Ma W, Zhang J, Song X, Sun W, Fan Y. The immunoregulatory activities of astragalus polysaccharide liposome on macrophages and dendritic cells. Int J Biol Macromol. 2017;105(Pt 1):852–861. doi:10.1016/j.ijbiomac.2017.07.108
   PubMed Web of Science ®Google Scholar
• Sadeghi R, Razzaghdoust A, Bakhshandeh M, Nasirinezhad F, Mofid B. Nanocurcumin as a radioprotective agent against radiation-induced mortality in mice. Nanomed J. 2019;6(1):43–49.
   Google Scholar
• Shi HS, Gao X, Li D, et al. A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation. Int J Nanomedicine. 2012;7:2601–2611. doi:10.2147/IJN.S31439
   PubMed Web of Science ®Google Scholar
• Cabral H, Kataoka K. Progress of drug-loaded polymeric micelles into clinical studies. J Control Release. 2014;190:465–476. doi:10.1016/j.jconrel.2014.06.042
   PubMed Web of Science ®Google Scholar
• Kheiri Manjili H, Ghasemi P, Malvandi H, Mousavi MS, Attari E, Danafar H. Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles. Eur J Pharm Biopharm. 2017;116:17–30. doi:10.1016/j.ejpb.2016.10.003
   PubMed Web of Science ®Google Scholar
• Phan QT, Le MH, Le TT, Tran TH, Xuan PN, Ha PT. Characteristics and cytotoxicity of folate-modified curcumin-loaded PLA-PEG micellar nano systems with various PLA:PEG ratios. Int J Pharm. 2016;507(1–2):32–40. doi:10.1016/j.ijpharm.2016.05.003
   PubMed Web of Science ®Google Scholar
• Liu L, Sun L, Wu Q, et al. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis. Int J Pharm. 2013;443(1–2):175–182. doi:10.1016/j.ijpharm.2012.12.032
   PubMed Web of Science ®Google Scholar
• Song Z, Feng R, Sun M, et al. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivo. J Colloid Interface Sci. 2011;354(1):116–123. doi:10.1016/j.jcis.2010.10.024
   PubMed Web of Science ®Google Scholar
• Alshamrani M, Sikder S, Coulibaly F, Mandal A, Pal D, Mitra AK. Self-assembling topical nanomicellar formulation to improve curcumin absorption across ocular tissues. AAPS PharmSciTech. 2019;20(7):254. doi:10.1208/s12249-019-1404-1
   PubMed Web of Science ®Google Scholar
• Davis BM, Pahlitzsch M, Guo L, et al. Topical curcumin nanocarriers are neuroprotective in eye disease. Sci Rep. 2018;8(1):11066. doi:10.1038/s41598-018-29393-8
   PubMed Web of Science ®Google Scholar
• Duan Y, Cai X, Du H, Zhai G. Novel in situ gel systems based on P123/TPGS mixed micelles and gellan gum for ophthalmic delivery of curcumin. Colloids Surf B Biointerfaces. 2015;128:322–330. doi:10.1016/j.colsurfb.2015.02.007
   PubMed Web of Science ®Google Scholar
• Zeighamian V, Darabi M, Akbarzadeh A, et al. PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells. Artif Cells Nanomed Biotechnol. 2016;44(2):735–742. doi:10.3109/21691401.2014.982803
   PubMed Web of Science ®Google Scholar
• Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther. 2011;11(5):464–473. doi:10.4161/cbt.11.5.14410
   PubMed Web of Science ®Google Scholar
• Xie X, Tao Q, Zou Y, et al. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J Agric Food Chem. 2011;59(17):9280–9289. doi:10.1021/jf202135j
   PubMed Web of Science ®Google Scholar
• Lou J, Hu W, Tian R, et al. Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles. Int J Nanomedicine. 2014;9:2517–2525. doi:10.2147/IJN.S60270
   PubMed Web of Science ®Google Scholar
• Li Z, Barnes JC, Bosoy A, Stoddart JF, Zink JI. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev. 2012;41(7):2590–2605. doi:10.1039/c1cs15246g
   PubMed Web of Science ®Google Scholar
• Trewyn BG, Giri S, Slowing II, Lin VS. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem Commun (Camb). 2007;1(31):3236–3245. doi:10.1039/b701744h
   Web of Science ®Google Scholar
• Wu SH, Mou CY, Lin HP. Synthesis of mesoporous silica nanoparticles. Chem Soc Rev. 2013;42(9):3862–3875. doi:10.1039/c3cs35405a
   PubMed Web of Science ®Google Scholar
• Sun X, Wang N, Yang LY, Ouyang XK, Huang F. Folic acid and PEI modified mesoporous silica for targeted delivery of curcumin. Pharmaceutics. 2019;11(9):430. doi:10.3390/pharmaceutics11090430
   PubMed Web of Science ®Google Scholar
• Ahmadi Nasab N, Hassani Kumleh H, Beygzadeh M, Teimourian S, Kazemzad M. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Artif Cells Nanomed Biotechnol. 2018;46(1):75–81. doi:10.1080/21691401.2017.1290648
   PubMed Web of Science ®Google Scholar
• Kotcherlakota R, Barui AK, Prashar S, et al. Curcumin loaded mesoporous silica: an effective drug delivery system for cancer treatment. Biomater Sci. 2016;4(3):448–459. doi:10.1039/c5bm00552c
   PubMed Web of Science ®Google Scholar
• Park JH, Shin EY, Shin ME, et al. Enhanced retinal pigment epithelium (RPE) regeneration using curcumin/alginate hydrogels: in vitro evaluation. Int J Biol Macromol. 2018;117:546–552. doi:10.1016/j.ijbiomac.2018.05.127
   Web of Science ®Google Scholar
• Huang Y, Hu L, Huang S, et al. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Int J Nanomedicine. 2018;13:8309–8323. doi:10.2147/IJN.S184379
   PubMed Web of Science ®Google Scholar
• Song Z, Lu Y, Zhang X, Wang H, Han J, Dong C. Novel curcumin-loaded human serum albumin nanoparticles surface functionalized with folate: characterization and in vitro/vivo evaluation. Drug Des Devel Ther. 2016;10:2643–2649. doi:10.2147/DDDT.S112039
   PubMed Web of Science ®Google Scholar
• Li C, Luo T, Zheng Z, Murphy AR, Wang X, Kaplan DL. Curcumin-functionalized silk materials for enhancing adipogenic differentiation of bone marrow-derived human mesenchymal stem cells. Acta Biomater. 2015;11:222–232. doi:10.1016/j.actbio.2014.08.009
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang L, Peng H, Li Y, Xiong J, Xu Z. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo. Mater Sci Eng C Mater Biol Appl. 2013;33(8):4802–4808. doi:10.1016/j.msec.2013.07.047
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces. 2010;79(1):113–125. doi:10.1016/j.colsurfb.2010.03.039
   PubMed Web of Science ®Google Scholar
• Chaniyilparampu RN, Nair AK, Parthasarathy K, et al. Curcuminoids and its metabolites for the application in allergic ocular/nasal conditions. Int Publication Number. 2010;25:WO2010109482A2.
   Google Scholar
• Zhang J, Sun H, Zhou N, Zhang B, Ma J. Preparation and evaluation of biodegradable scleral plug containing curcumin in rabbit eye. Curr Eye Res. 2017;42(12):1597–1603. doi:10.1080/02713683.2016.1242753
   PubMed Web of Science ®Google Scholar
• Steigerwalt R, Nebbioso M, Appendino G, et al. Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Med. 2012;54(1 Suppl 4):11–16.
   PubMed Web of Science ®Google Scholar
• Madhusudana Rao K, Krishna Rao KS, Ramanjaneyulu G, Ha CS. Curcumin encapsulated pH sensitive gelatin based interpenetrating polymeric network nanogels for anti cancer drug delivery. Int J Pharm. 2015;478(2):788–795. doi:10.1016/j.ijpharm.2014.12.001
   Web of Science ®Google Scholar
• Wei X, Senanayake TH, Bohling A, Vinogradov SV. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition. Mol Pharm. 2014;11(9):3112–3122. doi:10.1021/mp500290f
   Web of Science ®Google Scholar
• Mangalathillam S, Rejinold NS, Nair A, Lakshmanan VK, Nair SV, Jayakumar R. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale. 2012;4(1):239–250. doi:10.1039/c1nr11271f
   PubMed Web of Science ®Google Scholar
• Ji P, Wang L, Chen Y, Wang S, Wu Z, Qi X. Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution. Biomater Sci. 2020;8(1):462–472. doi:10.1039/c9bm01605h
   PubMed Web of Science ®Google Scholar
• Burgos-Morón E, Calderón-Montaño JM, Salvador J, Robles A, López-Lázaro M. The dark side of curcumin. Int J Cancer. 2010;126(7):1771–1775. doi:10.1002/ijc.24967
   PubMed Web of Science ®Google Scholar